Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population

BACKGROUND: More than 30% of Medicare beneficiaries and 40% of patients dually eligible for Medicare and Medicaid use opioids. With an estimated 8%-12% of patients developing an opioid use disorder (OUD) after initiating opioids, opioid misuse is a significant public health challenge, especially amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferries, Erin, Racsa, Patrick, Bizzell, Brock, Rhodes, Clay, Suehs, Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390915/
https://www.ncbi.nlm.nih.gov/pubmed/33908274
http://dx.doi.org/10.18553/jmcp.2021.27.5.596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390915/
https://www.ncbi.nlm.nih.gov/pubmed/33908274
http://dx.doi.org/10.18553/jmcp.2021.27.5.596

Ejemplares similares